Inhibition of Knops antisera using soluble CR1
CR1 peptide . | McCa-1 . | McCa-2 . | McCb . | Sla-1 . | Sla-2 . | Sla-3 . | Sla-4 . | Vil . |
---|---|---|---|---|---|---|---|---|
PBS control | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-ABCD3-150 | I | I | NI | I | I | I | I | NI |
LHR-A | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-B | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-D+ | I | I | NI | I | I | I | I | NI |
CR1 peptide . | McCa-1 . | McCa-2 . | McCb . | Sla-1 . | Sla-2 . | Sla-3 . | Sla-4 . | Vil . |
---|---|---|---|---|---|---|---|---|
PBS control | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-ABCD3-150 | I | I | NI | I | I | I | I | NI |
LHR-A | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-B | NI | NI | NI | NI | NI | NI | NI | NI |
LHR-D+ | I | I | NI | I | I | I | I | NI |
NI indicates no inhibition; I, inhibition.
We have previously shown that LHR-D+ has the phenotype McC(a+b−), Sl(a+).
Therefore, only anti-McCa and Sla are inhibited and not the antithetical sera McCb or Vil.
Two different anti-McCa and 4 anti-Sla sera were used in the inhibition tests.